Key Points:
- IPO Launch: Kronox Lab Sciences IPO is set to open on June 3rd.
- Price Band: The floor price is 12.90 times the face value, while the cap price is 13.60 times the face value.
- Issue Size: No fresh issue; only an offer-for-sale (OFS) of 95.7 lakh equity shares.
- Allocation: 15% for non-institutional investors (NII), 35% for retail investors, and 50% for qualified institutional buyers (QIB).
- Basis of Allotment: Tentatively finalized on June 6th, with refunds initiated on June 7th.
- Listing Date: Shares expected to be listed on BSE and NSE on June 10th.
About Kronox Lab Sciences:
- The company specializes in producing high-purity specialty fine chemicals for various industries.
- Their products are used in pharmaceuticals, nutraceuticals, scientific research, agrochemicals, and more.
- They offer over 185 products, serving customers in India and over 20 other countries worldwide.
Financial Highlights:
- From March 2022 to March 2023, the company’s profit after tax (PAT) rose by 21.94%, with revenue increasing by 16.99%.
IPO Details:
- The IPO comprises only an offer-for-sale (OFS) of 95.7 lakh equity shares by selling shareholders.
- The promoters, Jogindersingh Jaswal, Ketan Ramani, and Pritesh Ramani, are each offloading 31.9 lakh shares.
- Book Running Lead Manager: Pantomath Capital Advisors Pvt Ltd; Registrar: Kfin Technologies Limited.
Grey Market Premium (GMP) Today:
- The GMP for Kronox Lab Sciences IPO stands at +80, indicating a premium of ₹80 in the grey market.
- Expected Listing Price: ₹216 apiece, 58.82% higher than the IPO price of ₹136.
‘Grey market premium’ reflects investors’ willingness to pay more than the issue price.
Disclaimer: The views and investment tips expressed by investment experts on Sharepriceindia.com are their own and not those of the website or its management. Sharepriceindia.com advises users to check with certified experts before taking any investment decisions.
ADVERTISEMENT
ADVERTISEMENT
